arrow_back Trending Legislation
Share share

Mandating Diversity and Reducing Burden in NIH-Funded Clinical Trials.

This Act requires NIH-funded clinical trials to set measurable goals for recruiting participants that reflect the racial, ethnic, age, and sex diversity of the patient population, ensuring that new treatments are safe and effective for all demographic groups. It also mandates the implementation of less burdensome follow-up options for participants, such as virtual or home visits, and requires a study on improving compensation for time and out-of-pocket expenses.
Key points
Clinical trials must establish clear recruitment goals to reflect the race, ethnicity, age, and sex diversity of the patient population being studied.
Research organizations must offer less burdensome follow-up options for participants, including telemedicine, home visits, or use of wearable technology.
The NIH will study modernizing regulations to better reimburse participants for out-of-pocket expenses and compensate them for their time.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
NIH Clinical Trial Diversity Act of 2023
Print number: S 1701
Sponsor: Sen. Menendez, Robert [D-NJ]
Process start date: 2023-05-18